CClinicalTrials.gg
CompletedNCT07080580Updated Jul 25, 2025

Vibration-Assisted Core Exercises for Primary Dysmenorrhea

An interventional study of Core exercises performed simultaneously on a whole body vibration platform in Dysmenorrhea Primary, sponsored by Ebru Aloğlu Çiftçi. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2025-07-25.

Sponsored by Ebru Aloğlu Çiftçi · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled Apr 2023, registered Jul 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

This study aims to evaluate the effects of core stabilization exercises performed on a vibration platform in young women with primary dysmenorrhea. The exercises are designed to help reduce menstrual symptoms and pain, and to improve attitudes toward menstruation, functional and emotional well-being, and quality of life. A total of 24 women participated in the study. Participants were assigned either to a group receiving vibration-assisted core exercises or to a control group receiving no intervention. The intervention lasted 8 weeks, with sessions held three times per week.

Read the detailed description

Primary dysmenorrhea (PD) is a common gynecological condition characterized by uterine-origin lower abdominal pain during or before menstruation in the absence of any pelvic pathology. This randomized controlled trial aims to investigate the effects of a core exercise (CE) program performed on a vibration-supported platform on pain intensity, menstrual attitudes, quality of life, and functional and emotional status in women with PD. A total of 24 women aged 18 to 35 years participated in the study. Participants were randomly assigned to either an intervention group (n=12) or a control group (n=12). The intervention group performed vibration-assisted CE on a portable platform three times per week for eight weeks. The control group received no intervention. All participants were evaluated within the first 48 hours of the menstrual cycle, with follow-up assessments at weeks 4, and a final evaluation at the end of week 8.

02

Conditions studied

  • Dysmenorrhea Primary

Keywords

  • Vibration
  • dysmenorrhea primary
  • core exercise
  • whole body vibration
03

In context

Lead sponsor

Ebru Aloğlu Çiftçi is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  1. Being in the 18-28 age group.
  2. Being diagnosed with primary dysmenorrhea on an ultrasound examination.
  3. Having a Body Mass Index (BMI) between 19-24.9.
  4. Describing pain intensity as 5 or higher on the VAS pain scale.
  5. Having regular menstrual cycles (every 21-35 days and no intermenstrual bleeding) for the past 6 months.
  6. Being willing to participate in the study.
  7. Being cooperative and oriented.
  8. Not having had any fractures, dislocations, or joint injuries in the past 6 months.
  9. Not having had any surgery in the past 6 months.

Exclusion criteria

Exclusion Criteria:

  1. Having a systemic or chronic disease,
  2. Being a professional athlete,
  3. Having secondary dysmenorrhea,
  4. Using oral contraceptives,
  5. Being pregnant,
  6. Having an orthopedic, neurological, rheumatological, or cardiovascular problem that prevents exercise,
  7. Having any balance problems (vertigo, etc.) that prevent exercise.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Whole Body Vibration

    The vibration group performed core exercises with vibration at 8 mm amplitude and 14 Hz frequency, 3 days a week for 8 weeks (24 sessions). Each session lasted 45-60 minutes, including a 10-minute warm-up (walking) and a 5-minute cool-down (stretching). Vibration time started at 15 minutes and increased to 30 minutes. Eight core exercises (bridge exercise, plank, cat-camel exercise, crunches, side-bends, heel drops, squats, half push-ups) were applied, with repetitions increased every 2 weeks: 8 reps in weeks 1-2, 10 reps in weeks 3-4, 12 reps in weeks 5-6, and 15 reps in weeks 7-8. A 30-second rest was given between exercises.

    Behavioral: Core exercises performed simultaneously on a whole body vibration platform

  • No intervention
    Control Group

    No intervention was applied to the control group.

Interventions

  • BehavioralCore exercises performed simultaneously on a whole body vibration platform

    It's a method where individuals stand on a vibration-generating platform and the vibration is transmitted from the soles of their feet to the entire body. Its use in combination with exercise has become popular in recent years due to the hypergravity it creates, aiming to increase muscle strength and reduce pain. There is no standardized protocol for the frequency, amplitude, and frequency of vibration application. However, it is known that when applied at frequencies between 10-30 Hz, it has no negative side effects and is beneficial in managing pain. In our study, core exercises will be performed on a vibration platform at a frequency of 14 Hz with an amplitude of 8 mm.

06

What researchers measure

Primary outcomes

  1. Functional and Emotional Status Assessment (Functional and Emotional Dysmenorrhea Scale)

    The Functional and Emotional Dysmenorrhea Scale was used to assess participants' dysmenorrhea experiences functionally and emotionally. The scale is a Likert-type scale consisting of 14 items and two subscales. Each item can be scored from 1 to 5. Scoring criteria are: 1. Not at all like my situation, 2. Not at all like my situation, 3. Both similar and not like my situation, 4. Similar to my situation, 5. Very similar to my situation. As the total score on the scale increases, the extent to which individuals are functionally and emotionally affected by dysmenorrhea also increases.

    Time frame: First 48 hours of the menstrual cycle (pre-intervention), week 4 (post-intervention), week 8 (post-intervention)

  2. Menstruation Symptoms (Menstruation Symptom Scale)

    In our study, the Menstrual Symptom Scale, a useful tool for assessing menstrual symptoms in Turkish women and found to have adequate validity and reliability, was used to assess participants' symptoms. The scale consists of 22 items developed to assess dysmenorrhea and its symptoms. Each item can be scored from 1 to 5. Scoring criteria range from 1 (never) to 5 (always). It consists of three subscales: items 1-13 address negative effects/somatic complaints, items 14-19 address menstrual pain symptoms, and items 20-22 address coping strategies. The subscale score is calculated by calculating the total mean score of the items in the subscales. A higher mean score for a subscale indicates an increase in the severity of menstrual symptoms related to that subscale. The mean score calculated from the scale is directly proportional to the severity of menstrual symptoms.

    Time frame: First 48 hours of the menstrual cycle (pre-intervention), week 4 (post-intervention), week 8 (post-intervention)

  3. Menstruation Attitudes (Menstruation Attitude Questionnaire)

    In our study, we used the Menstruation Attitude Questionnaire to measure attitudes toward menstruation in individuals with dysmenorrhea and varying socio-demographic characteristics. The scale is a Likert-type scale consisting of 33 items and 5 subscales. Each item is scored from 1 to 5. Scoring criteria range from 1 (Strongly disagree) to 5 (Strongly agree). The subscales and number of items are as follows: 1. Menstruation as a debilitating phenomenon (12 items); 2. Menstruation as a disturbing phenomenon (6 items); 3. Menstruation as a natural phenomenon (5 items); 4. Precognition/Anticipation of menstruation (5 items); and 5. Denial of the effects of menstruation (7 items). A high mean score on the Menstruation Attitude Questionnaire is directly proportional to the positive attitude toward menstruation.

    Time frame: First 48 hours of the menstrual cycle (pre-intervention), week 4 (post-intervention), week 8 (post-intervention)

Secondary outcomes

  1. Pain Intensity (Visual Analog Scale)

    VAS is a frequently used assessment method for converting the intensity of pain, which cannot be measured numerically, into numerical data. Pain intensity is assessed on a scale from 0 to 10, with 0 indicating no pain and 10 indicating unbearable pain.

    Time frame: First 48 hours of the menstrual cycle (pre-intervention), week 4 (post-intervention), week 8 (post-intervention)

  2. Quality of Life Assessment (Short Form-36 Scale)

    The SF-36 is a self-assessment tool consisting of eight subscales and 36 questions. This tool is grouped to assess participants' physical functioning (10 items), physical limitations (4 items), emotional limitations (3 items), pain limitations (2 items), vitality (4 items), social functioning (2 items), mental health (5 items), and general health (5 items). Each subscale can be scored from 0 to 100. In this scoring system, 0 represents the lowest quality of life, and 100 represents the best.

    Time frame: First 48 hours of the menstrual cycle (pre-intervention), week 4 (post-intervention), week 8 (post-intervention)

  3. Trunk endurance assessment (Sorenson Test)

    In the Sorenson Test, participants were positioned prone, their pelvises positioned at the edge of the table, and their ankles were stabilized. The upper extremities were positioned next to the torso. The time the participant could maintain the horizontal position was measured with a stopwatch. The test was terminated if the position could not be maintained.

    Time frame: First 48 hours of the menstrual cycle (pre-intervention), week 4 (post-intervention), week 8 (post-intervention)

  4. Trunk endurance assessment (Sit-up testi)

    In the sit-up test, the maximum number of correct repetitions that the subjects perform within a 30-second time period is recorded.

    Time frame: First 48 hours of the menstrual cycle (pre-intervention), week 4 (post-intervention), week 8 (post-intervention)

  5. Trunk endurance assessment (Lateral Bridge Test-Right and Left)

    The Side Bridge Test was performed to assess the endurance of the spinal stabilizer muscles. Participants were positioned in a side-lying position. They were asked to lift their hips until the pelvis and trunk were horizontal. The time the position was maintained was measured with a stopwatch, and the assessment was performed on both sides.

    Time frame: First 48 hours of the menstrual cycle (pre-intervention), week 4 (post-intervention), week 8 (post-intervention)

07

Study locations

1 site
  • Istanbul Okan University
    Istanbul, Tuzla 34959, Turkey (Türkiye)
08

References and documents

Publications

  • Lefebvre G, Pinsonneault O, Antao V, Black A, Burnett M, Feldman K, Lea R, Robert M; SOGC. Primary dysmenorrhea consensus guideline. J Obstet Gynaecol Can. 2005 Dec;27(12):1117-46. doi: 10.1016/s1701-2163(16)30395-4. English, French. PubMed 16524531 ↗
  • Hoseini, M., Gharahtapeh, S. R., Jahazi, A. 2015 "Effect Of Vibration And Heat Combination On Primary Dysmenorrhea" Bali Medical Journal, 4(1), 12-16.

Individual participant data

Plan to share: Yes — The study will share de-identified, summary-level outcome data, including group-level means, standard deviations, effect sizes, and p-values derived from statistical analyses.

Supporting information: Study protocol, Sap

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07080580
Lead sponsor
Ebru Aloğlu Çiftçi
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Ebru Aloğlu Çiftçi (Lecturer, Istinye University) — Sponsor-investigator
First posted
Jul 23, 2025
Start date
Apr 20, 2023
Primary completion
Aug 17, 2024
Completion
Sep 17, 2024
Last update
Jul 25, 2025

Study contacts

EBRU ALOĞLU ÇİFTÇİ, Lecturer
principal investigator · Okan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion